Ondansetron HCL 4 MG tablet 500S
Ended Awarded
- Contract number
- SPE2DR26F0FHZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,417
Award facts
- Contract value 100% obligated
- $20,416.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $20,416.60 delivery order to Amerisourcebergen Drug Corp on June 8, 2026, for ondansetron HCL 4 mg tablets (500 count), with ultimate completion on June 9, 2026.
The order is firm fixed-price with no set-aside. Place of performance is Conshohocken, PA. The ceiling value and obligated amount are both $20,416.60.
Quick answers
Who was awarded contract SPE2DR26F0FHZ?
SPE2DR26F0FHZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 8, 2026.
How much is contract SPE2DR26F0FHZ worth?
The government has obligated $20,417 on SPE2DR26F0FHZ.
Is contract SPE2DR26F0FHZ an order under another contract?
Yes. SPE2DR26F0FHZ is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F0FHZ competed?
The extent of competition for SPE2DR26F0FHZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award